Summary
The FDA is seeking research to develop Physiologically Based Pharmacokinetic (PBPK) model-based mechanistic In Vitro-In Vivo Correlations (IVIVCs) for long-acting injectable suspensions and implants. This is a U01 cooperative research grant mechanism, meaning the FDA will have substantial scientific and/or programmatic involvement. Clinical trials are optional under this opportunity. The effort aims to advance drug product development science and regulatory tools for extended-release parenteral dosage forms.